bf/NASDAQ:ARWR_icon.jpeg

NASDAQ:ARWR

Arrowhead Pharmaceuticals, Inc.

  • Stock

USD

Last Close

39.60

06/11 22:30

Market Cap

3.33B

Beta: 1.01

Volume Today

1.19M

Avg: 1.11M

PE Ratio

−16.68

PFCF: −12.05

OverviewFinancialsAPI

    Description

    Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -1-0.50.512018-08-072020-02-052021-11-222023-05-022024-12-04

    Revenue (Estimate*)

    200M400M600M800M1B2018-08-072020-02-052021-11-222023-05-022024-12-04

    *Estimate based on analyst consensus